World Mental Health Day is observed on 10 October every year, Mental Health deserves to be nurtured to make human societies better places to live in
Bengaluru: With an unwavering focus on the comprehensive development of students, CMR University (CMRU) Bengaluru, is observing the World Mental Health Day on 8 October 2021.
This hour-long virtual program, called “Unmute and Echo” is conducted by the students of the Psychedelic Club at the School of Social Sciences and Humanities at CMRU. Key focus of the event is on “Mental Health In Today’s Uncertain Scenarios”. This activity is conducted in the Slam Poetry form. It combines elements of performance, creative writing, and competition by the students; besides inviting participation from the audience.
The Psychedelic Club aims to encourage and promote mental health awareness and build a greater understanding of the field of psychology. As discussions on mental health are still a matter of contemplation in human society, students at CMRU have consciously chosen the theme of Mental Wellness to bring discussions revolving around mental health to the mainstream in India.
The intention is to create awareness of the need to openly discuss mental illness and get treated scientifically.
The participants in the Slam Poetry will get 5-6 minutes to perform. Registration for this online event is free and can be done through Google Forms at https://forms.gle/vWWuRWF4gLv57JG28
The event is slated to be held on 8th October 2021 between 2.30 pm and 3.30 pm. It is open to students of all universities. The last date to register is 7th October before 5.00 pm.
The World Health Organization (WHO) observes World Mental Health Day on 10 October every year. This year’s theme set by the World Federation for Mental Health is “ Health in an Unequal World”.
For more information, please contact: Dr Radhika CA M: 9945411955 Email : radhika.c@cmr.edu.in
Dr. Hema Divakar, Vice-Chair of FIGO Pregnancy & NCD committee, emphasizes easy storage and availability of ampoules in hospitals
BELAGAVI: Renowned healthcare leader Dr. Hema Divakar, the Vice-Chair of Pregnancy & NCD (Non-Communicable Diseases) Committee, International Federation of Gynecology and Obstetrics (FIGO), today emphasized the need for easy availability, storage, and timely administration of medicine to prevent excessive bleeding (postpartum hemorrhage) among women after childbirth, which is one of the major reasons for higher maternal mortality rate (MMR) in underdeveloped nations.
Dr. Hema, who is also the CEO of Bengaluru-based ARTIST for Her (Asian Research and Training Institute for Skill Transfer), made the observations here today at the global launch of the RTS Carbetocin Ferring at the Women’s and Children’s Health Unit, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research. To mark the occasion, 1,000 ampoules of Carbetocin (medicine to control postpartum hemorrhage) were handed over for free to the unit.
Such medicines currently available in the country require special storage conditions, including refrigeration. On the contrary, Carbetocin is heat stable and does not require refrigeration, ideal for use in developing and underdeveloped countries where power supply is not stable. This is for the first time that Carbetocin is being administered in India.
When Dr. Hema was the president of FOGSI (Federation of Obstetric and Gynaecological Societies of India), she championed institutionalizing the administration of medicine to prevent bleeding after birth; sensitizing the healthcare providers about the need for refrigerated storage of the medicine and administering it within one minute after delivery. From 2013, under her leadership and with the help of FOGSI champions, the implementation of the protocol for appropriate use of the medicine to prevent postpartum hemorrhage increased to more than 68% in many parts of India through the ‘Helping Mothers Survive’ campaign.
“Today, it is standard protocol for hospitals, both private and government, to administer medicine to women soon after they deliver the baby. This has significantly contributed to the reduction of MMR in India. It is all the more important in our country because over 50% of pregnant women are anemic, and if such women bleed excessively, the incidence of deaths due to postpartum hemorrhage becomes even higher if this medicine is not administered in time,” pointed out Dr.Hema.
Sharing similar views, Dr. S. Shantha Kumari, President, FOGSI, said the organization had intensified its efforts to educate hospitals and train the healthcare workers on various protocols through special campaigns. “It is our objective to minimize postpartum hemorrhage by maximizing the implementation and the practice of the protocol of administering medicine in time,” she added.
Dr. N. Rajkumar, Deputy Director of Maternal Health, Department of Health & Family Welfare Services, Government of Karnataka; Dr. Prabhakar B Kore, Chairman, KEL Society and Dr. Vivek A Saoji, Vice-Chancellor, KLE Academy of Higher Education and Research were among the dignitaries present on the occasion.
For More Information, please contact: Dr. Hema Divakar Consultant ObGyn and Medical Director Divakars Speciality Hospital, Bengaluru PRESIDENT FOGSI 2013 Organising Chairman AICOG 2019 CEO – ARTIST (Asian Research and Training Institute for Skill Transfer) FOGSI Ambassador to FIGO (Federation of International Gynaecologists and Obstetricians) M: 9844046724 | Email: drhemadivakar@gmail.com
14 April 2021: City Ophthalmologist, Dr Soosan Jacob, Director and Chief, Refractive and Cornea Foundation, and Senior Consultant, Cataract and Glaucoma Services at Dr. Agarwal’s Group of Eye Hospitals, India, enters the international Power List – 2021, a list of Top 100 most influential women ophthalmologists in the world.
The prestigious Power List is compiled every year by ‘The Ophthalmologist’, a premier international publication dedicated to the field of Ophthalmology and selection is on the basis of national and international recognition among peer Ophthalmologists.
Dr Soosan Jacob has over 21 years of experience, specializing in Cornea, Refractive surgery and Cataract surgery. Her other fields of interest in ophthalmology include cutting edge cataract, complex and complicated cases, anterior segment reconstruction procedures, glaucoma and orbit and oculoplasty.
Commenting about the entry of his colleague in the Power List 2021, Prof. Amar Agarwal, Chairman, Dr Agarwal’s Group of Eye Hospital, said, “My heartfelt congratulations to Dr. Soosan, who fully deserves this honor. It is a proud moment for everyone at Dr Agarwal’s Group. Dr. Jacob has been making exemplary contributions, especially to the cornea and refractive surgical field with many of her innovative surgical techniques – notable and recent among them being a novel technique called Corneal Allogeneic Intrastromal Ring Segment (CAIRS) to treat keratoconus, a more and more commonly seen condition in which the clear tissue on the front of the eye bulges outward. Her innovations have been life-changing for patients. My best wishes for many more laurels to come her way.”
In her comments, Dr Soosan Jacob, Director and Chief, Refractive and Cornea Foundation, and Senior Consultant, Cataract and Glaucoma Services said, “I am honored to be on this prestigious Power List of the Top 100 most influential women ophthalmologists in the world, a list that’s awaited eagerly every year. Initiatives like The Power List are important as they celebrate all the awesome, wonderful women ophthalmologists who show the way forward and inspire other brilliant women. For women, it is important to break glass ceilings to achieve their full potential. I must say that I have been fortunate both at home and at work to be in environments where it is considered crucial to empower women,” she said.
Dr Soosan Jacob has been the recipient of several prestigious international awards including International Society of Refractive Surgery’s Kritzinger Memorial Award; Connecticut Society of
Eye Physicians’ Innovator’s Award, The Waring Medal, European Society of Cataract and Refractive Surgery’s John Henahan Award for Young Ophthalmologist, American Academy of Ophthalmology’s International Ophthalmologist Education Award and many international Oration awards.
She is a noted speaker and author – she has authored more than 100 peer reviewed publications, is the editor for 17 ophthalmology textbooks, is on the editorial board of prestigious international journals and on the executive committee of many international ophthalmological organizations. She conducts courses and delivers lectures in numerous national and international conferences and has been invited to teach her techniques at many international institutes such as Bascom Palmer Eye Institute, USA, Jules Gonin Eye Institute, Switzerland etc. Her surgical teaching YouTube channel has more than 10,000 subscribers.
Bengaluru / April 9, 2021: Delhi-based Dr. Kalyan Banerjee’s Clinic has developed a world-class homeopathy protocol for prevention of Covid-19, which it has dispensed to 2 lakh people in the last one year, helping protect them from the dreaded pandemic. It is counted among the world’s most popular homeopathic prophylaxis protocols today, and the only one to have been validated in an evidence-based manner.
Dr. Kalyan Banerjee, Founder, Dr. Kalyan Banerjee’s Clinic, New Delhi, said, “The homeopathic prophylaxis protocol was developed by us even before the lockdown started. One of the world’s largest datasets of 15,000 of our own patients from 18 countries was then analysed and a protective effect of the prophylaxis protocol was found. Senior doctors at our Clinic have been involved in the management of severe COVID-19 cases, including multiple organ dysfunction syndrome, and are managing more than 100 Covid patients daily. They have also administered the our protocol to Covid patients from all over the world exclusively or as an add-on.”
He added: “Dr. Kalyan Banerjee’s Clinic homeopathy prophylaxis protocol against Covid-19 has been requested by patients and doctors from several hospitals of the world in advanced stages of the disease. We have developed protocols according to case severity and provided these to various organisations on their request. We, of course, encouraged compliance with all public health advisories at all times, no matter where in the world the patient was located.”
There is an old relationship of Dr. Banerjee’s Clinic with Bengaluru. It has more than 25,000 patients in the city. The Clinic at Delhi processes more than 600 telephone, video or email consultation requests from Bengaluru each month. Between 120-150 patients visit Delhi from Bengaluru every month to seek treatment at Dr. Kalyan Banerjee’s Clinic. Said Dr. Kushal Banerjee from Dr. Kalyan Banerjee Clinic, who visits Bengaluru once a month to see patients: “A lacunae in the homeopathic management of life threatening and complicated cases has been highlighted by patients in Bengaluru. Almost a quarter of the patients we see from the city are seeking treatment for respiratory allergies. Others are suffering from skin allergies, auto-immune disorders, cancers, endocrinological disorders, musculoskeletal disorders or gynaecological disorders.”
In another significant development, Dr. Banerjee’s Clinic has released findings from ongoing retrospective observational studies it has been conducting involving data of thousands of its patients from all over India. These show the benefits of homeopathy interventions in the management of chronic kidney disease / kidney failure and hypothyroidism, two very common diseases which have no resolution in conventional medicine.
Hypothyroidism imposes a heavy disease burden with 11% prevalence in India, higher than in developed nations. Lifelong hormone replacement therapy is the only option for patients. An average of 40 cases of hypothyroidism are treated daily at Dr. Kalyan Banerjee’s Clinic. Measuring the levels of Thyroid-stimulating hormone (TSH) is a simple, objective criteria to assess the efficacy of treatment.
The hypothyroidism study at Dr. Kalyan Banerjee’s Clinic analysed the records of 3,500 patients. Their Serum TSH readings were noted at every subsequent visit. Four visits of each patient were analysed with approximate follow-up period of 4 to 24 months. The study found that by the fourth visit, 35-52% of patients demonstrated a marked improvement in their serum TSH readings.
The data indicates that specific homeopathic medicines given to patients were able to improve the functioning of the thyroid gland, thereby bringing down the thyroid stimulating hormone readings. This has the potential of reducing – or entirely stopping – the dosage of thyroid hormone replacement in patients. This runs contrary to the understanding of the natural history of hypothyroidism, which indicates that the progression of the disease is usually not controlled.
Said Dr. Kushal Banerjee from Dr. Kalyan Banerjee Clinic, “This study shows that at the minimum, a third of all hypothyroid patients stand to benefit from homeopathy treatment protocols developed at our Clinic. No other similar therapeutic intervention is available today. Population studies up to now have indicated that there should be no change in the disease progression of these patients. This reversal of progression should be of immense research interest to the healthcare community and indicates a positive therapeutic effect of the specific homeopathic treatment provided to the patients.”
Added Dr. Kalyan Banerjee, “As shown by the study, at least 35% of patients of hypothyroidism stand to benefit from the specific homeopathic treatment provided at Dr. Kalyan Banerjee’s Clinic. This includes, in almost all the patients who demonstrated improvement, a combination of two homeopathic medicines – Ignatia Amara 200c & Conium Maculatum 3c. This indicates the possible discovery of novel medicinal action of these two medicines for the management of hypothyroidism.”
Doctors of Dr. Banerjee’s Clinic also treat an average of 25 cases of chronic kidney disease (CKD) per day. The CKD study conducted by the Clinic analysed raw data from the records of 520 new. Their Serum Urea and Creatinine readings were noted in every subsequent visit. Three visits of each patient at the Clinic were analyzed, with approximate follow up period of 3 to 6 months. The study found that by the third visit, 50% of patients demonstrated significant improvement in their serum urea and creatinine readings. No currently available treatment can affect such a reduction in these two most clinically important readings. Since these readings are a part of the decision-making process of whether to start dialysis or not, homeopathic treatment may help patients avoid the start of dialysis.
Said Dr. Kushal Banerjee, “At the minimum, 50% of the patients of chronic kidney disease stand to benefit from the specific homeopathic treatment provided at Dr. Kalyan Banerjee’s Clinic. This offers the possibility of avoiding or delaying the onset of dialysis. No other similar therapeutic intervention is available today. Serum creatinine and urea levels along with eGFR are used to stage patients of CKD. Reduction in these levels may mean reduction of stage. This has never been demonstrated before. In almost all patients who have demonstrated improvement, a combination of two homeopathic medicines – Bryonia Alba 30c & Lycopodium 30c – was used. This indicates the possible discovery of novel medicinal action of these two homeopathic medicines for the management of CKD.”
Added Dr. Kalyan Banerjee, “These are early findings, but we encourage all doctors to consider the provision of homeopathic treatment for patients of these conditions. The homeopathic medicines have a proven high safety profile and cause no adverse reactions with any other medicines. They are safe to use. We will be happy to work with specialists in these fields to conduct robust trials and collaborate with research bodies to understand the mechanism of action of these remedies for CKD and hypothyroidism.”
Dr. Kalyan Banerjee’s Clinic has over 550,000 registered patients. Its doctors see more than 1,000 patients every day.
26 March 2021: In a first in India, Meenakshi Mission Hospital and Research Centre (MMHRC), Madurai, one of South India’s leading multi-specialty hospitals, has deployed 16 mobile Teladoc Health Robots for clinical examinations, diagnosis, and monitoring of health parameters of both out-patients and in-patients. These robots are the preferred choice of the world’s top six hospitals. MMHRC is the only healthcare institution in India to deploy these.
Said Dr. S. Gurushankar, Chairman, Meenakshi Mission Hospital, Madurai: “These telemedicine robots from Teladoc are a substantial addition to the healthcare capabilities available in Tamil Nadu. They have empowered our doctors to treat patients anywhere and anytime. We can now get expert opinion from a specialist anywhere in the world. Doctors from different disciplines can come together to treat a patient. They can also monitor patients 24/7. This capability has helped us save many lives during the times of the ongoing pandemic.”
The Teladoc telemedicine robots have capabilities to carry out basic clinical examinations (such as checking blood pressure and heart rate) on their own, as instructed by the doctors. As IoT devices, they can be used to control other advanced diagnostic equipment such as CT and MRI scan machines. Applying Artificial Intelligence, the robots can collect and process data from other diagnostic equipment and present it to the doctors to help them make precise clinical decisions. The robots can also enhance patient relations, as they are fitted with cameras and display monitors to enable patient-doctor interaction.
Dr. Gurushankar said the adoption of such telemedicine robots is not going to take away jobs of paramedical staff. Their primary objective is to augment the diagnostic abilities of doctors and improve access, quality, and efficiency of healthcare delivery for patients irrespective of their physical location – whether they are admitted at the hospital or are miles away at their home.
Dr. Gurushankar said that mobile telemedicine robots are getting increasingly popular across the world since the outbreak of COVID-19, as these help hospitals reduce the risk of infections of all types substantially. Meenakshi Mission Hospital is all set to explore ways to use this novel technology to provide expert diagnosis from Madurai to patients in other parts of the country so as to put world-class healthcare within everyone’s reach.
Meenakshi Mission Hospital is spearheading the adoption of AI, robotics, telemedicine, and other technological breakthroughs in healthcare. During the lockdown days of the Covid pandemic, it deployed robots to detect Covid symptoms in people, sanitize the hospital premises, and deliver food and medicines to in-patients, as part of its 6-stage protection against Coronavirus.
City Today News 
You must be logged in to post a comment.